Matthew M. Gubin

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

Chih‐Hao Chang, Jing Qiu, David O’Sullivan et al. · Cell · 2015 · 3.1K citations · Full text

Tumor Biology, Oncology, Medicine +11

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin, Xiuli Zhang, Heiko Schuster et al. · Nature · 2014 · 2K citations · Full text

MHC-II neoantigens shape tumour immunity and response to immunotherapy

Elise Alspach, Danielle M. Lussier, Alexander P. Miceli et al. · Nature · 2019 · 837 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Mhc-ii Neoantigens +6

TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy

Martina Molgora, Ekaterina Esaulova, William Vermi et al. · Cell · 2020 · 605 citations · Full text

Cancer Immunosurveillance, Medicine, T-regulatory Cell +10

High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy

Matthew M. Gubin, Ekaterina Esaulova, Jeffrey P. Ward et al. · Cell · 2018 · 407 citations · Full text

Tumor Biology, Lymphoid Neoplasia, Medicine +9